|
|
|
|
|
|
|
|
open access: Survival and Control Prognosticators of Recurrent Gynecological Malignancies of the Pelvis and Para-aortic Region Treated with Stereotactic Body Radiation Therapy | Radiation Oncology
The 2-year LC rate of cervical, endometrioid uterine, and ovarian/non-endometrioid uterine recurrences was 100, 82, and 33, respectively.
Conclusion
Although limited by a small patient population and the
intrinsic selection bias of a retrospective review, our data
corroborates the promising survival and control rates of pelvic and PA
gynecologic recurrences treated by SBRT. The toxicity profile is low
especially with PSW and PAN recurrence; however, caution should be used
with bigger centrally recurring tumors as they are in close proximity to
the rectum/bladder, increasing the risk for fistulas in particular if
the target region received previous radiation. Retrospective series such
as this one suggest that SBRT is emerging as the salvage therapy of
choice for select recurrent gynecologic malignancies in the pelvis and
PA region when brachytherapy is not possible. Prospective trials would
help determine ideal patient selection to maximize efficacy and limit
toxicity.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.